Systematic review of 29 studies: stopping oral 5-ASA monotherapy in quiescent ulcerative colitis was associated with more relapse (RR 1.60), as was stopping rectal 5-ASA (RR 2.03). Stopping 5-ASA alongside immunomodulators or biologics was not (very low/low certainty).
Meta-analysisn = 29 studies
Arzivian et al. The Risk of Relapse Associated With Discontinuation of 5-Aminosalicylates in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis